Loading…
Lobbying Income
$14.3M
Filings
385
Unique Clients
12
Active Period
2014–2023
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
VALID Act of 2023
2023 · fourth_quarter · Client: MAYO COLLABORATIVE SERVICES, INC.
Issues impacting diagnostics including FDA regulation of laboratory developed tests; H.R.2369, VALID Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R.2369
CBD Product Safety and Standardization Act of 2023
2023 · third_quarter · Client: NATURAL PRODUCTS ASSOCIATION
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; H.R.1628, CBD Product Safety and Standardization Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1628
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
2023 · third_quarter · Client: NATURAL PRODUCTS ASSOCIATION
FDA regulations and legislation affecting dietary supplements, medical foods and other natural products; regulations and legislation related to foods and dietary supplements containing CBD; Coronavirus impact and response; H.R.1629, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023; H.R.1628, CBD Product Safety and Standardization Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1629
Saving Access to Laboratory Services Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.2377
Diagnostic Lab Testing Transparency Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3248
Improving DATA in Public Health Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.3791
Preparedness and Response Reauthorization Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.4420
Preparing for All Hazards and Pathogens Reauthorization Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.4421
Saving Access to Laboratory Services Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: S.1000
Pandemic and All-Hazards Preparedness and Response Act
2023 · third_quarter · Client: AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)
Implementation of Protecting Access to Medicare Act of 2014, P.L.113-93 (changes to reimbursement for clinical laboratory services). Policies impacting Medicare coverage and reimbursement for clinical laboratory services. FDA regulation of clinical laboratory services. Coronavirus impact and response. H.R.2377/S.1000, Saving Access to Laboratory Services Act. H.R.3791, Improving DATA in Public Health Act. H.R.3248, Diagnostic Lab Testing Transparency Act. FY 2024 budget and appropriations process. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $50,000
Matched citations: S.2333
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805, Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375, The HELP Copays Act. H.R.5539, The ORPHAN Cures Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1350
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805, Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375, The HELP Copays Act. H.R.5539, The ORPHAN Cures Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1805
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805, Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375, The HELP Copays Act. H.R.5539, The ORPHAN Cures Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5539
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805, Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375, The HELP Copays Act. H.R.5539, The ORPHAN Cures Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.830
Issues related to the development of therapies for rare diseases and sleep disorders; sleep health equity; drug pricing; and access to non-controlled medications. H.R.1350, Camerons Law. FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. H.R.1805, Leos Law. Issues related to the implementation of Inflation Reduction Act Medicare Part D redesign policy. H.R.830, S.1375, The HELP Copays Act. H.R.5539, The ORPHAN Cures Act.
Client expense: — · Firm income: $30,000
Matched citations: S.1375
Resident Physician Shortage Reduction Act of 2023
2023 · third_quarter · Client: BAYLOR COLLEGE OF MEDICINE
Issues related to neglected tropical diseases, space biomedical research, medical schools, health research, animal research, childhood nutrition, vaccines and immunizations; Coronavirus impact and response; Advanced Research Project Agency-Health issues; H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R.2389
Resident Physician Shortage Reduction Act of 2023
2023 · third_quarter · Client: BAYLOR COLLEGE OF MEDICINE
Issues related to neglected tropical diseases, space biomedical research, medical schools, health research, animal research, childhood nutrition, vaccines and immunizations; Coronavirus impact and response; Advanced Research Project Agency-Health issues; H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: S.1302
Prescription Information Modernization Act of 2023
2023 · third_quarter · Client: Viatris Inc
Legislation and regulations related to pharmaceuticals and medical products, and access to affordable medicines; Coronavirus impact and response; pharmaceutical supply chain; policies impacting Medicare coverage and reimbursement for prescription drugs. H.R.1503, Prescription Information Modernization Act of 2023. S.127, Pharmacy Benefit Manager Transparency Act of 2023. S.775, Increasing Transparency in Generic Drug Applications Act. Issues related to President's Emergency Plan For Aids Relief (PEPFAR). H.R.5378, Lower Costs, More Transparency Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.1503
Legislation and regulations related to pharmaceuticals and medical products, and access to affordable medicines; Coronavirus impact and response; pharmaceutical supply chain; policies impacting Medicare coverage and reimbursement for prescription drugs. H.R.1503, Prescription Information Modernization Act of 2023. S.127, Pharmacy Benefit Manager Transparency Act of 2023. S.775, Increasing Transparency in Generic Drug Applications Act. Issues related to President's Emergency Plan For Aids Relief (PEPFAR). H.R.5378, Lower Costs, More Transparency Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R.5378
Pharmacy Benefit Manager Transparency Act of 2023
2023 · third_quarter · Client: Viatris Inc
Legislation and regulations related to pharmaceuticals and medical products, and access to affordable medicines; Coronavirus impact and response; pharmaceutical supply chain; policies impacting Medicare coverage and reimbursement for prescription drugs. H.R.1503, Prescription Information Modernization Act of 2023. S.127, Pharmacy Benefit Manager Transparency Act of 2023. S.775, Increasing Transparency in Generic Drug Applications Act. Issues related to President's Emergency Plan For Aids Relief (PEPFAR). H.R.5378, Lower Costs, More Transparency Act.
Client expense: — · Firm income: $30,000
Matched citations: S.127
Increasing Transparency in Generic Drug Applications Act
2023 · third_quarter · Client: Viatris Inc
Legislation and regulations related to pharmaceuticals and medical products, and access to affordable medicines; Coronavirus impact and response; pharmaceutical supply chain; policies impacting Medicare coverage and reimbursement for prescription drugs. H.R.1503, Prescription Information Modernization Act of 2023. S.127, Pharmacy Benefit Manager Transparency Act of 2023. S.775, Increasing Transparency in Generic Drug Applications Act. Issues related to President's Emergency Plan For Aids Relief (PEPFAR). H.R.5378, Lower Costs, More Transparency Act.
Client expense: — · Firm income: $30,000
Matched citations: S.775
Preparedness and Response Reauthorization Act
2023 · third_quarter · Client: ILLUMINA, INC.
Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding, National Institutes of Health funding, reauthorization of the Pandemic and All-Hazards Preparedness Act (S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act), and Biosecurity Infrastructure for Operational Early Warning Act (discussion draft).
Client expense: — · Firm income: $40,000
Matched citations: H.R.4420
Preparing for All Hazards and Pathogens Reauthorization Act
2023 · third_quarter · Client: ILLUMINA, INC.
Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding, National Institutes of Health funding, reauthorization of the Pandemic and All-Hazards Preparedness Act (S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act), and Biosecurity Infrastructure for Operational Early Warning Act (discussion draft).
Client expense: — · Firm income: $40,000
Matched citations: H.R.4421
Pandemic and All-Hazards Preparedness and Response Act
2023 · third_quarter · Client: ILLUMINA, INC.
Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding, National Institutes of Health funding, reauthorization of the Pandemic and All-Hazards Preparedness Act (S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act), and Biosecurity Infrastructure for Operational Early Warning Act (discussion draft).
Client expense: — · Firm income: $40,000
Matched citations: S.2333
Resident Physician Shortage Reduction Act of 2023
2023 · third_quarter · Client: ASSOCIATION OF AMERICAN MEDICAL COLLEGES
Policies impacting Medicare coverage and reimbursement for clinical laboratory services; Medicare and Medicaid funding for graduate medical education; Medicaid safety-net issues; Coronavirus impact and response; public health and pandemic preparedness. H.R.2389/S.1302, Resident Physician Shortage Reduction Act of 2023. H.R.2665, Supporting Safety Net Hospitals Act. Reauthorization of the Pandemic and All-Hazards Preparedness Act, S.2333, Pandemic and All-Hazards Preparedness and Response Act, H.R.4420, Preparedness and Response Reauthorization Act, H.R.4421, Preparing for All Hazards and Pathogens Reauthorization Act.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2389
Source: Senate LDA